A Matter of Equity People Living with Psychosis are Disproportionately Affected by Cannabis Adverse Events
This project analyzes data from the International Cannabis Policy Study, collected between 2020 and 2023. Its aims are to compare the prevalence of cannabis-related adverse effects among people who used cannabis in the last 12 months, according to their mental health diagnostic (no mental health diagnosis, psychotic disorder diagnosis, or any other mental health diagnosis but psychotic disorder).
Investigators
Beatriz Carlini, PhD, MPH
Sharon Garrett, MPH, MA
Jason Williams, PhD
David Hammond, PhD Collaborator at the University of Waterloo
Fund Information
Funded by the Washington State Legislature through ESSB 5187 (2023) and by the Washington State Dedicated Cannabis Fund for research at the University of Washington.
Start: October 2024
End: June 2025
Status: current
